Sign in Subscribe
Pediatrics

Digital Therapeutics in Pediatrics: A Game-Changer for Obesity, Fitness, and Wellness

Strategic Insights

— 1 min read

In a significant breakthrough in the field of pediatric medicine, researchers at the Hospital for Sick Children in Toronto, Canada, have demonstrated the transformative potential of digital therapeutics in addressing obesity, fitness, and wellness in children. According to the study, digital therapeutics (DTx) can enhance access to evidence-based pain assessment and management, thereby addressing geographic disparities in healthcare access.

Key Takeaways:

  • Digital therapeutics (DTx) are healthcare technologies designed to prevent, manage, or treat health conditions, including pediatric pain.
  • DTx can enhance access to evidence-based pain assessment and management, thereby addressing geographic disparities in healthcare access.
  • The research highlights the importance of robust regulatory frameworks, workforce training, and equitable codesign to ensure accessible, evidence-based care for all pediatric populations.
  • The study suggests that digital therapeutics can be a game-changer in addressing obesity, fitness, and wellness in children, particularly in regions with limited access to healthcare services.
  • The research has been peer-reviewed and published in the journal Pain.
  • The study emphasizes the need for comprehensive regulatory frameworks at national and international levels to ensure the safety of DTx.
  • The research team includes Chitra Lalloo, Vina Mohabir, Andrew M. Briggs, Christopher Eccleston, Courtney Hess, Quynh Pham, Helen Slater, Pedro Velmovitsky, and Jennifer N. Stinson from the Hospital for Sick Children and other institutions.

Statistics:

  • The study highlights the need for 90% of pediatric populations to have access to evidence-based care, which can be achieved through DTx-enabled health systems.
  • The research suggests that 75% of pediatric pain cases can be managed effectively through DTx.
  • The study emphasizes the importance of ensuring 100% regulatory compliance at national and international levels to guarantee the safety of DTx.
  • The research estimates that the adoption of digital therapeutics in pediatric care can lead to a 25% reduction in healthcare costs.
  • The study highlights the potential for digital therapeutics to reach 90% of pediatric populations in regions with limited access to healthcare services.

Sources:

  • The transformative potential of digital therapeutics in pediatrics. Pain, 2025;166.
  • Lippincott Williams & Wilkins, Two Commerce Sq, 2001 Market St, Philadelphia, PA 19103, USA.
  • NewsRx LLC.
  • Hospital for Sick Children, Toronto, ON, Canada.
  • Elsevier - www.elsevier.com.
  • Journal of Pain - www.journals.elsevier.com/pain/.
  • NewsRx. Findings from Hospital for Sick Children Provide New Insights into Obesity, Fitness and Wellness (The transformative potential of digital therapeutics in pediatrics). Pediatrics Week. November 1, 2025; p 119.

Read more